Home / Advanced Search

  • Title/Keywords

  • Author/Affliations

  • Journal

  • Article Type

  • Start Year

  • End Year

Update SearchingClear
  • Articles
  • Online
Search Results (8)
  • Open Access

    ARTICLE

    The Effect and Mechanism of Thalidomide in Ameliorating Crohn’s Disease-Related Intestinal Fibrosis

    Xiaoyue Feng1,#, Yu Liu2,#, Ying Kang1, Juan Wei2, Bei Yuan3, Kang Jiang4, Weijun Xu2, Xinyi Xia5, Fangyu Wang1,*

    BIOCELL, Vol.49, No.8, pp. 1505-1528, 2025, DOI:10.32604/biocell.2025.066504 - 29 August 2025

    Abstract Objectives: A common side effect of inflammatory bowel disease (IBD) is intestinal fibrosis, which frequently leads to intestinal blockage and stricture formation. Although Thalidomide (THD) has shown anti-fibrotic benefits in hepatic and renal models, little is known about how it affects intestinal fibrosis and the underlying processes. The present research examines the molecular targets of THD and its potential as a treatment for intestinal fibrosis brought on by colitis. Methods: Clinical samples from Crohn’s disease (CD) patients with intestinal strictures treated with infliximab (IFX) and THD combined with IFX were collected. Dextran sulfate sodium (DSS)… More >

  • Open Access

    CASE REPORT

    Differential Diagnosis between Primary Intracranial Melanoma and Cerebral Cavernoma in Crohn’s Disease: A Case Report and Literature Review

    Roberta Costanzo1, Vishal Parmar2, Salvatore Marrone1, Domenico Gerardo Iacopino1, Giovanni Federico Nicoletti3, Giuseppe Emmanuele Umana4, Gianluca Scalia3,*

    Oncologie, Vol.24, No.4, pp. 937-942, 2022, DOI:10.32604/oncologie.2022.027155 - 31 December 2022

    Abstract Primary intracranial melanomas are rare, with a challenging diagnosis based only on clinical and imaging features. The authors described the case of an intracerebral right parieto-temporal melanoma mimicking a cavernoma in a patient affected by Crohn’s disease. A 67-year-old female patient with Crohn’s disease and small bowel stenosis was hospitalized for surgical removal of the terminal ileum and latero-lateral ileo-colic anastomosis. During postoperative week 1, the patient developed psychomotor agitation followed by altered consciousness. An urgent brain CT showed a right intracerebral parieto-temporal hemorrhage with intralesional calcifications. The patient underwent a decompressive craniectomy with hematoma More >

  • Open Access

    REVIEW

    Efficacy of oral consumption of curcumin/ for symptom improvement in inflammatory bowel disease: A systematic review of animal models and a meta-analysis of randomized clinical trials

    MARLA DE CERQUEIRA ALVES1, MONISE OLIVEIRA SANTOS1, NASSIB BEZERRA BUENO1, ORLANDO ROBERTO PIMENTEL DE ARAÚJO2, MARÍLIA OLIVEIRA FONSECA GOULART2,3,4, FABIANA ANDRÉA MOURA1,5,*

    BIOCELL, Vol.46, No.9, pp. 2015-2047, 2022, DOI:10.32604/biocell.2022.020407 - 18 May 2022

    Abstract

    The roots of the vegetal Curcuma due to its high content of polyphenols, has been used successfully in several clinical situations. This review assessed the effect of curcumin/Curcuma longa on symptoms and metabolic changes in inflammatory bowel disease (IBD). A systematic review of animal models and randomized clinical trials (RCTs) was conducted by searching the following electronic databases: PubMed, CENTRAL, LILACS, Science Direct, and ClinicalTrials.gov. From 997 found records, 62 were included. More than 90% of the animal studies reported an improvement in macroscopic, histologic and/or functional activity; 80% identified decreased oxidative and/or inflammatory biomarkers in

    More >

  • Open Access

    REVIEW

    A review of urinary fistulae in Crohn’s disease

    Gregory Wade1, Stanley Zaslau2, Robert Jansen2

    Canadian Journal of Urology, Vol.21, No.2, pp. 7179-7184, 2014

    Abstract Introduction: Urinary fistulae develop as abnormal connections between the gastrointestinal (GI) and genitourinary (GU) tracts, and occur in multiple disease processes including diverticulitis, malignancy, and Crohn’s disease. Crohn’s disease is now the most common cause of fistula formation between the ileum and bladder and the third most common cause of fistulae between the colon and the bladder. Few articles provide a comprehensive review of this process.
    Materials and methods: We performed a PubMed search using such terms as “fistula” and “Crohn’s disease” and/or “enterovesical fistula.” We reviewed references from selected papers and relevant articles were used for… More >

  • Open Access

    REVIEW

    Treatment failure with antagonists of TNF-α: mechanisms and implications for the care of patients

    Marine Desroches, Gauthier Louis, Aude Gleizes, Roman Krzysiek, Dominique Emilie

    European Cytokine Network, Vol.21, No.4, pp. 226-231, 2010, DOI:10.1684/ecn.2010.0212

    Abstract The use of TNF-α antagonists has substantially improved the care of many patients with inflam-matory and autoimmune diseases. However, approximately one third of such patients fail to respond well totreatment, regardless of the antagonist used or of the underlying disease. The mechanisms underlying these fail-ures are analyzed in this review, and proposals made concerning how best to adapt therapeutic decisions inthese instances. More >

  • Open Access

    ARTICLE

    Peripheral cytokine profile in Chilean patients with Crohn’s disease and ulcerative colitis

    Caroll J. Beltrán1,2*, Enzo Candia1*, Benjamín Erranz1, Carolina Figueroa3, Maria J. Gonzalez4, Rodrigo Quera3,5, Marcela A. Hermoso1

    European Cytokine Network, Vol.20, No.1, pp. 33-38, 2009, DOI:10.1684/ecn.2009.0142

    Abstract Crohn’s disease (CD) and ulcerative colitis (UC) belong to the group of inflammatory bowel dis-eases (IBD), with complex ethiopathogenic factors that include an unbalanced immune and inflammatory response to commensal and food antigens. The differential diagnosis between CD and UC is performed using clinical, endoscopic, histopathological, serological and radiological methods; however between 10-15% of IBD patients are diagnosed as “unclassified colitis”. Further research into IBD is necessary in order to develop addi-tional diagnostic tools. The aim of this work was to see if the Th1, Th17 or Th2 immune pattern, represented by CD4+ lymphocytes producing… More >

  • Open Access

    ERRATUM

    Erratum for Beltrán CJ, et al. Eur Cytokine Netw 2008 ; 1: 33-8. Peripheral cytokine profile in Chilean patients with Crohn’s disease and ulcerative colitis

    Caroll J. Beltrán1,2, Enzo Candia1, Benjamín Erranz1, Carolina Figueroa3, Maria J. Gonzalez4, Rodrigo Quera3,5, Marcela A. Hermoso1

    European Cytokine Network, Vol.20, No.2, pp. 94-94, 2009, DOI:10.1684/ecn.2009.0151

    Abstract This article has no abstract. More >

  • Open Access

    REVIEW

    NOD2 engagement induces proinflammatory cytokine production, but not apoptosis, in leukocytes isolated from patients with Crohn’s disease

    Evelien Bodar1,3, Mihai G. Netea1,3, Dirk J. de Jong2, Bart-Jan Kullberg1,3, Leo A. B. Joosten1,3, Jos W. M. Van der Meer1,3

    European Cytokine Network, Vol.19, No.4, pp. 185-189, 2008, DOI:10.1684/ecn.2008.0140

    Abstract Background. NOD2/CARD15 is a member of the NACHT-LRR (NLR) family of proteins, which recognize the muramyl dipeptide motif from bacterial peptidoglycans. NOD2 has been shown to be involved in the pathogenesis of Crohn’s disease. NLR proteins modulate inflammation and apoptosis, and several studies have implicated NOD2 in the induction of cytokines and inflammatory reactions. However, only scarce data are available regarding its role in apoptosis. Donors and methods. Neutrophils and lymphocytes isolated from the blood from four Crohn’s disease patients homozygous for the loss-of-function 3020insC NOD2 mutation were examined for spontaneous and anisomycin-induced apoptosis. They More >

Displaying 1-10 on page 1 of 8. Per Page